Dataset Information


Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma.

ABSTRACT: MYC is a transcriptional factor that regulates growth and proliferation through cell cycle pathways. MYC alterations, in particular MYC rearrangements, are important in assessing the prognosis of aggressive B-cell lymphoma. In this study, we focused on the impact of nine major cell cycle genes for MYC-driven aggressive mature B-cell lymphoma and analyzed the mutational status using targeted next generation sequencing. Our 40 cases of aggressive mature B-cell lymphomas included 5 Burkitt lymphomas, 17 high-grade B-cell lymphomas and 18 diffuse large B-cell lymphomas with MYC breaks in 100%, 88% and 11%, respectively. Our data allowed a molecular classification into four categories partially independent from the histopathological diagnosis but correlating with the Ki-67 labelling index: (I) harboring TP53 and CDKN2A mutations, being highly proliferative, (II) with MYC rearrangement associated with MYC and/or ID3 mutations, being highly proliferative, (III) with MYC rearrangement combined with additional molecular changes, being highly proliferative, and (IV) with a diverse pattern of molecular alterations, being less proliferative. Taken together, we found that mutations of TP53, CDKN2A, MYC and ID3 are associated with highly proliferative B-cell lymphomas that could profit from novel therapeutic strategies.

SUBMITTER: Yamashita T 

PROVIDER: S-EPMC7596913 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5451341 | BioStudies
2015-01-01 | S-EPMC4335296 | BioStudies
1000-01-01 | S-EPMC5649549 | BioStudies
2018-01-01 | S-EPMC5902834 | BioStudies
1000-01-01 | S-EPMC5291628 | BioStudies
2017-01-01 | S-EPMC5477607 | BioStudies
2012-01-01 | S-EPMC3674561 | BioStudies
2015-01-01 | S-EPMC4915334 | BioStudies
2012-01-01 | S-EPMC5070713 | BioStudies
2014-01-01 | S-EPMC4892842 | BioStudies